Skip to main content

OrbiMed Capital GP IX LLC

In the past year, 1 open-market purchase filing worth $34.9M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$34.9M
1 filing
Sold
–
0 filings
Net
+$34.9M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists OrbiMed Capital GP IX LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BRVE Braveheart Bio, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 11, 2026 (view filing)5:27 PM ETAug 74 daysOrbiMed Advisors LLC and 2 othersDirector, 10% OwnerPPurchase+1.94M$18.00+$34.9MNew position273.3K after2 lots

STTK Shattuck Labs, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 15, 2026 (view filing)6:12 PM ETJun 114 daysOrbiMed Advisors LLC and 2 othersDirectorPPurchase+1.25M–––5.30M afterDerivative2 lotsDuplicate filing
Sep 2, 2025 (view filing)9:52 PM ETAug 258 daysLateOrbiMed Advisors LLC and 2 othersDirectorPPurchase+6.31M$0.8677+$5.47MNew position1.05M after2 lots
Sep 2, 2025 (view filing)9:52 PM ETAug 258 daysLateOrbiMed Advisors LLC and 2 othersDirectorPPurchase+30.6M–––3.07M afterDerivative4 lotsDuplicate filing